48
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Prior Invasive Pulmonary and Cerebellar Mucormycosis is not a Primary Contraindication to Perform an Autologous Stem Cell Transplatation in Leukemia

, , , , , , & show all
Pages 657-659 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Lizbeth Cahuayme-Zuniga, Russell E. Lewis, Victor E. Mulanovich & Dimitrios P. Kontoyiannis. (2012) Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies. Medical Mycology 50:5, pages 543-548.
Read now
B Gleissner, A Schilling, I Anagnostopolous, I Siehl & E Thiel. (2004) Improved Outcome of Zygomycosis in Patients with Hematological Diseases?. Leukemia & Lymphoma 45:7, pages 1351-1360.
Read now

Articles from other publishers (2)

Andrea Piccin, John D. Russell, Patrick Fleming, Karina Butler, Michael McDermott, Owen P. Smith & Aengus O'Marcaigh. (2006) Invasive rhino‐maxillary mucormycosis diagnosed before HSCT. Pediatric Blood & Cancer 50:2, pages 393-395.
Crossref
Hiroshi Yasui, Yasushi Adachi, Yoshifumi Ishii, Yasuo Kato & Kohzoh Imai. (2003) Mucormycosis as an etiology of cerebral hemorrhage in patients with chronic neutrophilic leukemia. The American Journal of Medicine 115:8, pages 674-676.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.